<DOC>
	<DOCNO>NCT00126763</DOCNO>
	<brief_summary>The purpose study evaluate safety matrix fentanyl patch ZR-02-01 providing relief non-malignant chronic pain .</brief_summary>
	<brief_title>Fentanyl Transdermal Matrix Patch ZR-02-01 Treat Chronic , Moderate Severe Non-Malignant Pain</brief_title>
	<detailed_description>This study evaluate safety matrix fentanyl patch . The study conduct opioid-tolerant patient moderate severe non-malignant chronic pain currently take around-the-clock opioid . Patients discontinue current opioid regimen begin use ZR-02-01 soon possible direction physician investigator upon entry study . Patient 's dose ZR 02 01 determine investigator use sponsor-provided conversion . Pain therapy supervision physician investigator .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patient least 18 old 75 year age Patient moderate severe , nonmalignant chronic pain expect last least 12 month currently take aroundtheclock opioid treat his/her pain Patient already receive opioid therapy , demonstrate opioid tolerance , require total daily dose opioids least equivalent 25 mcg/hr transdermal fentanyl . Patients consider opioidtolerant take daily dose least 30 mg oral morphine morphine equivalent opioid least 2 week . Patient active cancer Patient history substance abuse substance abuse disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>Pain</keyword>
</DOC>